The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Fuca, G; Guarini, V; Antoniotti, C; Morano, F; Moretto, R; Corallo, S; Marmorino, F; Lonardi, S; Rimassa, L; Sartore-Bianchi, A; Borelli, B; Tampellini, M; Bustreo, S; Claravezza, M; Boccaccino, A; Murialdo, R; Zaniboni, A; Tomasello, G; Loupakis, F; Adamo, V; Tonini, G; Cortesi, E; de Braucl, F; Cremolini, C; Pietrantonio, F